Working Group Says Evidence Does Not Support CYP450 Testing with Antidepressants | GenomeWeb
NEW YORK (GenomeWeb News) – A panel formed by the US Centers for Disease Control and Prevention’s National Office of Public Health Genomics has said that it currently would not recommend cytochrome P450 gene testing with selective serotonin reuptake inhibitor drugs used for treating depression.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.